Practice
Featured experience
Quanta Computer strategic collaboration with and investment in Rigetti
We are advising Quanta on the transaction
Avianca senior secured notes offering and exchange offer and consent solicitation
The transactions included a $1 billion senior secured notes offering and a $1.1 billion exchange offer and consent solicitation
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Spirit Airlines prearranged chapter 11 filing
We are advising Spirit Airlines in connection with entry into an RSA and negotiation of a prearranged chapter 11 plan
McKesson $850 million acquisition of controlling interest in PRISM Vision
We are advising McKesson on the transaction
Maze Therapeutics $140 million IPO
The shares are listed on Nasdaq
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S…
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
InVue sale to ASSA ABLOY
We advised InVue on the transaction
Ferrero Group acquisition of Power Crunch
We are advising Ferrero on the transaction
Arcos Dorados renewal of long-term master franchise agreement with McDonald’s
We advised Arcos Dorados on the transaction
Rokt $300 million merger with mParticle
We are advising Rokt on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction